Settling RWA in won: Which step does KRW1 aim to eliminate?
An institution holding Korean won that wants to buy on-chain tokenized assets may have to convert its funds and settle in dollars if the market only accepts dollar stablecoins. This partnership between Injective and BDACS aims to add another option: trading and settling relevant assets directly in Korean won. The most useful thing for readers is to understand what this route is intended to connect to, and which access points have yet to be confirmed.
On October 21, Beijing time, I reviewed the full announcement dated October 20 on Injective’s official website. The two parties have signed a memorandum of understanding and plan to introduce BDACS-issued KRW1 into Injective’s RWA and tokenization ecosystem. The announcement clearly states that minting and redemption will be available to approved institutional partners, subject to regulatory approval; specific use cases will be updated after launch. This review involved reading the official statement, not testing minting or redemption.
The purpose is to give won-denominated funds a chance to avoid part of the dollar settlement route. My limited assessment is that if an asset is already priced in won, and the entry point, quotes, and exit all support won, this route may better match funding needs. But if the underlying asset remains exposed to dollar cash flows or other price risks, merely switching the settlement currency to KRW1 will not automatically eliminate those risks. Whether it is worthwhile also depends on eligibility, conversion costs, and liquidity, and the announcement does not provide a complete answer.
You can save these three checks:
① Check eligibility and approvals: Find out which institutions this route accepts and what approvals are required. Without the relevant conditions, you cannot assume from a general product description that you can mint or redeem directly.
② Check the actual market: Look for this deployment on-chain, the specific RWA market, and its quotes and settlement currency. A signed agreement or a launch on another chain is not enough to confirm that this route is usable.
③ Check the exit terms: Verify fees, minimum amounts, waiting times, and how failures are handled. If information is missing, mark it as unknown for now; do not estimate net costs or assume funds will arrive.
Market attention and product progress should also be considered separately. Binance INJ/USDT fell about 0.73% over the full hour from 01:00 to 02:00, with trading volume of about 642,000 USDT—0.40 times the average of the previous five complete hours. This is market context for the related token; it does not prove KRW1 adoption, and the cumulative RWA figures across the entire network in the announcement should not be counted as business volume for this partnership.
What is worth watching for next is the first verifiable market, along with complete terms for access and exit. Only once this evidence is available will it be possible to make a more informed comparison of the actual differences between the won and dollar routes. $INJ
An institution holding Korean won that wants to buy on-chain tokenized assets may have to convert its funds and settle in dollars if the market only accepts dollar stablecoins. This partnership between Injective and BDACS aims to add another option: trading and settling relevant assets directly in Korean won. The most useful thing for readers is to understand what this route is intended to connect to, and which access points have yet to be confirmed.
On October 21, Beijing time, I reviewed the full announcement dated October 20 on Injective’s official website. The two parties have signed a memorandum of understanding and plan to introduce BDACS-issued KRW1 into Injective’s RWA and tokenization ecosystem. The announcement clearly states that minting and redemption will be available to approved institutional partners, subject to regulatory approval; specific use cases will be updated after launch. This review involved reading the official statement, not testing minting or redemption.
The purpose is to give won-denominated funds a chance to avoid part of the dollar settlement route. My limited assessment is that if an asset is already priced in won, and the entry point, quotes, and exit all support won, this route may better match funding needs. But if the underlying asset remains exposed to dollar cash flows or other price risks, merely switching the settlement currency to KRW1 will not automatically eliminate those risks. Whether it is worthwhile also depends on eligibility, conversion costs, and liquidity, and the announcement does not provide a complete answer.
You can save these three checks:
① Check eligibility and approvals: Find out which institutions this route accepts and what approvals are required. Without the relevant conditions, you cannot assume from a general product description that you can mint or redeem directly.
② Check the actual market: Look for this deployment on-chain, the specific RWA market, and its quotes and settlement currency. A signed agreement or a launch on another chain is not enough to confirm that this route is usable.
③ Check the exit terms: Verify fees, minimum amounts, waiting times, and how failures are handled. If information is missing, mark it as unknown for now; do not estimate net costs or assume funds will arrive.
Market attention and product progress should also be considered separately. Binance INJ/USDT fell about 0.73% over the full hour from 01:00 to 02:00, with trading volume of about 642,000 USDT—0.40 times the average of the previous five complete hours. This is market context for the related token; it does not prove KRW1 adoption, and the cumulative RWA figures across the entire network in the announcement should not be counted as business volume for this partnership.
What is worth watching for next is the first verifiable market, along with complete terms for access and exit. Only once this evidence is available will it be possible to make a more informed comparison of the actual differences between the won and dollar routes. $INJ